• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Fat Tail Daily

Investment Ideas From the Edge of the Bell Curve

  • Menu
    • Commodities
      • Resources and Mining
      • Copper
      • Gold
      • Iron Ore
      • Lithium
      • Silver
      • Graphite
      • Rare Earths
    • Technology
      • AI
      • Bitcoin
      • Cryptocurrency
      • Energy
      • Financial Technology
      • Bio Technology
    • Market Analysis
      • Latest ASX News
      • Dividend Shares
      • ETFs
      • Stocks and Bonds
    • Macro
      • Australian Economy
      • Central Banks
      • World Markets
    • Small Caps
    • More
      • Investment Guides
      • Premium Research
      • Editors
      • About
      • Contact Us
  • Latest
  • Fat Tail Series
  • About Us
Latest

Markets Get Their Shot in the Arm

Like 1

By Charlie Ormond, Thursday, 27 November 2025

We've become dependent on the Fed's needle. Every wobble gets smoothed over with dovish speeches and rate cut hints. Another shot in the arm to send stocks higher.

The ‘Steroid Olympics’ is going public.

No, really.

The Enhanced Games, a new athletics competition where doping isn’t just allowed, it’s encouraged, announced this week it’s merging with a blank-cheque company in a US$1.2 billion deal.

Backed by Peter Thiel and Donald Trump Jr, the venture promises ‘Super Bowl-level’ half-time shows, and athletes juiced to the gills chasing world records.

World Athletics president Lord Sebastian Coe called it ‘nonsense’ and said any athlete who participates would be ‘moronic’.

The market apparently disagrees. Paradise Acquisition Corp is taking this thing to Nasdaq.

As I read this news, I couldn’t help but notice the parallels.

Currently, markets are seeking their own shot in the arm.

The Great Backflip

Last week was ugly.

AI doubts triggered a US$3 trillion sell-off. Rate cut hopes evaporated. The probability of the Fed cutting in December sat at a measly 30%.

Then came one of those classic reversals that’s all too familiar for anyone who’s watched central banks in the past.

A parade of dovish Fed speakers changed the tune. In just four days, rate cut expectations rocketed from 30% to nearly 90%.

Narratives shifted. Markets rallied. The S&P 500 is back to eyeing the magic 7,000-point barrier.

Veteran market watcher Mohamed El-Erian wasn’t impressed:

‘So much for forward policy guidance fostering stability and predictability.’

But investors don’t care about consistency. They care about the juice.

And right now, the Fed looks ready to deliver.

The Fed’s Beige Book

The latest Fed survey painted a bland picture, fitting its name.

Everything shifted, ‘slightly’, things moved ‘moderately’. But little shone positively.

Hiring fell across half the Fed’s regional districts. Consumers are pulling back. The recent government shutdown left federal workers — and the businesses that serve them — reeling.

Source: Barrons, LSEG

The shutdown has also been cited as an excuse for not releasing the October Jobs report, the CPI (inflation) report, and the quarterly GDP report.

But I’m sure everything is fine… right guys?

Reports or no, things are looking challenging in the US jobs market while costs rise.

It’s the classic central banking dilemma: a sputtering job market versus sticky prices.

Yet markets have made up their mind. An 84.5% chance of a cut in two weeks.

How Big Can You Be?

Let’s get back to our juiced-up athletes.

The Enhanced Games have attracted some serious names. British Olympic swimmer Ben Proud and American sprinter Fred Kerley have signed up.

Source: BBC – Ben Proud (looking juiced)

The first event is scheduled for Las Vegas next May. Swimming, athletics, and weightlifting. No drug tests. Just pure, chemically-assisted performance.

CEO Maximilian Martin claims that ‘performance enhancements, under the right clinical and medical supervision, can deliver long-term health and longevity benefits‘.

It’s a bold pitch. The investor presentation is less optimistic.

It warns of coordinated opposition from sports federations and anti-doping agencies. Venues and sponsors could distance themselves due to ‘sustained negative publicity’.

To get the ball rolling, they are projecting a US$37 million operating loss on US$52 million in revenue next year.

But backers include the Winklevoss twins and a Saudi prince. The deal values the company at US$1.2 billion.

Welcome to 2025, where a loss-making steroid sports league commands a billion-dollar valuation.

Sound familiar?

Juice Those Numbers

Here’s my concern with markets right now.

We’ve become dependent on the Fed’s needle. Every wobble gets smoothed over with dovish speeches and rate cut hints.

Another shot in the arm to send stocks higher.

In my opinion, markets are pricing in a lot of good news: rate cuts, reacceleration, and AI miracles.

If you’re positioned aggressively, consider whether you’re comfortable with that bet.

If you’re unsure, then make sure to keep your eyes peeled this week for a special Fat Tail Roundtable Event.

All Editors here at Fat Tail are sitting down for what could be our most consequential think tank session of 2026.

We’re talking markets, bubbles, valuations and what comes after AI.

If you’ve got any skin in the game, this could be the meeting to help you position for the new year.

If the Enhanced Games teach us anything, it’ll likely be that performance enhancement works — until it doesn’t.

The gains are spectacular. The side effects? Ask us in a few years.

Regards,

Charlie Ormond,
Small-Cap Systems and Altucher’s Investment Network Australia

All advice is general advice and has not taken into account your personal circumstances.

Please seek independent financial advice regarding your own situation, or if in doubt about the suitability of an investment.

Comments

Subscribe
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments
Charlie Ormond

With more than a decade of fintech experience, including stretches in critical roles at budding start-ups and tech titans like Microsoft, Charles is squarely focused on investment opportunities in emerging sectors. Interestingly, his academic foundation in zoology provides an unexpected edge! He applies his scientific training with his analytical mindset to figure out tomorrow’s winners and losers. While traditional institutions stick with ‘safe’ stocks, Charles goes straight for seismic shifts in crypto and AI. He’s an early adopter of both technologies.

Now he’s on a mission to empower everyday investors. He decodes groundbreaking developments in technology stocks before they grab mainstream attention. So, if you seek an unconventional perspective to help capitalise on what’s next in fintech, look no further.

Charlie’s Premium Subscriptions

Publication logo
Alpha Tech Trader

Latest Articles

  • Much Ado About Nothing
    By Charlie Ormond

    Art of the Deal or TACO is asking the wrong question. What should we all learn from this moment?

  • China Capitulation Part 2 – What western analysts miss about China
    By Brian Chu

    In this article of my China Capitulation series, I show where western analysts get it wrong about China’s outlook. I delve into how the Chinese Communist Party sets plans and reports the data to show you why you can’t trust their narrative…

  • The Great Rotation Begins: Following the Aussie Dollar Back to Commodities
    By James Cooper

    The Aussie Dollar hit historic lows in 2001 before a commodity supercycle erupted. Are we seeing that pattern repeat today?

Primary Sidebar

Latest Articles

  • Much Ado About Nothing
  • China Capitulation Part 2 – What western analysts miss about China
  • The Great Rotation Begins: Following the Aussie Dollar Back to Commodities
  • Bond Revolt in Japan, Trump Next?
  • The Game of Diplomacy: Trump’s Greenland Gambit

Footer

Fat Tail Daily Logo
YouTube
Facebook
x (formally twitter)
LinkedIn

About

Investment ideas from the edge of the bell curve.

Go beyond conventional investing strategies with unique ideas and actionable opportunities. Our expert editors deliver conviction-led insights to guide your financial journey.

Quick Links

Subscribe

About

FAQ

Terms and Conditions

Financial Services Guide

Privacy Policy

Get in Touch

Contact Us

Email: support@fattail.com.au

Phone: 1300 667 481

All advice is general in nature and has not taken into account your personal circumstances. Please seek independent financial advice regarding your own situation, or if in doubt about the suitability of an investment.

The value of any investment and the income derived from it can go down as well as up. Never invest more than you can afford to lose and keep in mind the ultimate risk is that you can lose whatever you’ve invested. While useful for detecting patterns, the past is not a guide to future performance. Some figures contained in our reports are forecasts and may not be a reliable indicator of future results. Any actual or potential gains in these reports may not include taxes, brokerage commissions, or associated fees.

Fat Tail Logo

Fat Tail Daily is brought to you by the team at Fat Tail Investment Research

Copyright © 2026 Fat Tail Daily | ACN: 117 765 009 / ABN: 33 117 765 009 / ASFL: 323 988